Skip to main content
. 2023 Jan 5;13(2):204. doi: 10.3390/diagnostics13020204

Figure 3.

Figure 3

Distribution of the 5-HT-iR cells in the patients with UC in remission (Mayo 0–1) and active UC (Mayo 2).